STARTUP PROFILE

GrayMatters Health

COUNTRY
Israel
FOUNDED
2018
CATEGORY
Neuromodulation
Developing Prism, an FDA-cleared neurofeedback system using EEG-based biomarkers to train self-regulation of brain networks in PTSD and depression.
Visit website →
Neurofounders Insights
$   Funding   -
Series B
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Psychiatry
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
GrayMatters Health is positioned in neurofeedback therapeutics, with FDA-cleared software targeting PTSD and depression through brain network self-regulation. Its clinical validation differentiates it from wellness-focused neurofeedback platforms.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
GrayMatters Health
No items found.